Sugarman J - Search Results

1

A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.

Schulman KA, Seils DM, Timbie JW, Sugarman J, Dame LA, Weinfurt KP, Mark DB, Califf RM. Schulman KA, et al. Among authors: sugarman j. N Engl J Med. 2002 Oct 24;347(17):1335-41. doi: 10.1056/NEJMsa020349. N Engl J Med. 2002. PMID: 12397192 Free article.

2

Monitoring and ensuring safety during clinical research.

Morse MA, Califf RM, Sugarman J. Morse MA, et al. Among authors: sugarman j. JAMA. 2001 Mar 7;285(9):1201-5. doi: 10.1001/jama.285.9.1201. JAMA. 2001. PMID: 11231751

3

Medicine. Placebo-controls in short-term clinical trials of hypertension.

Al-Khatib SM, Califf RM, Hasselblad V, Alexander JH, McCrory DC, Sugarman J. Al-Khatib SM, et al. Among authors: sugarman j. Science. 2001 Jun 15;292(5524):2013-5. doi: 10.1126/science.1057783. Science. 2001. PMID: 11408643 Review. No abstract available.

4

Blood money: ethical and legal implications of treating cord blood as property.

Dame L, Sugarman J. Dame L, et al. Among authors: sugarman j. J Pediatr Hematol Oncol. 2001 Oct;23(7):409-10. doi: 10.1097/00043426-200110000-00003. J Pediatr Hematol Oncol. 2001. PMID: 11878572 No abstract available.

5

Toward protecting the safety of participants in clinical trials.

Califf RM, Morse MA, Wittes J, Goodman SN, Nelson DK, DeMets DL, Iafrate RP, Sugarman J. Califf RM, et al. Among authors: sugarman j. Control Clin Trials. 2003 Jun;24(3):256-71. doi: 10.1016/s0197-2456(03)00005-9. Control Clin Trials. 2003. PMID: 12757992

6

Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.

Weinfurt KP, Dinan MA, Allsbrook JS, Friedman JY, Hall MA, Schulman KA, Sugarman J. Weinfurt KP, et al. Among authors: sugarman j. Acad Med. 2006 Feb;81(2):113-8. doi: 10.1097/00001888-200602000-00003. Acad Med. 2006. PMID: 16436571 Free PMC article.

7

Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure.

Weinfurt KP, Friedman JY, Allsbrook JS, Dinan MA, Hall MA, Sugarman J. Weinfurt KP, et al. Among authors: sugarman j. J Gen Intern Med. 2006 Sep;21(9):901-6. doi: 10.1111/j.1525-1497.2006.00502.x. J Gen Intern Med. 2006. PMID: 16918732 Free PMC article.

8

Measuring trust in medical researchers.

Hall MA, Camacho F, Lawlor JS, Depuy V, Sugarman J, Weinfurt K. Hall MA, et al. Among authors: sugarman j. Med Care. 2006 Nov;44(11):1048-53. doi: 10.1097/01.mlr.0000228023.37087.cb. Med Care. 2006. PMID: 17063137

9

Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.

Weinfurt KP, Friedman JY, Dinan MA, Allsbrook JS, Hall MA, Dhillon JK, Sugarman J. Weinfurt KP, et al. Among authors: sugarman j. J Law Med Ethics. 2006 Fall;34(3):581-91, 481. doi: 10.1111/j.1748-720x.2006.00072.x. J Law Med Ethics. 2006. PMID: 17144182 Free PMC article.

10

Developing model language for disclosing financial interests to potential clinical research participants.

Weinfurt KP, Allsbrook JS, Friedman JY, Dinan MA, Hall MA, Schulman KA, Sugarman J. Weinfurt KP, et al. Among authors: sugarman j. IRB. 2007 Jan-Feb;29(1):1-5. IRB. 2007. PMID: 17364012 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

586 results

Search Page